The way forward: dry powder inhalers should only be switched with physician agreement and patient training

Research output: Contribution to journalLiterature review

10 Citations (Scopus)

Abstract

Assessment of pharmaceutical performance, patient behaviour and clinical outcomes shows that dry powder inhalers cannot be used interchangeably, even if they contain the same active chemical entity. Consequently, there should be no switching of device without the involvement of the physician and appropriate training for the patient.

Original languageEnglish
Pages (from-to)36-37
Number of pages2
JournalInternational Journal of Clinical Practice
Volume59
Publication statusPublished - 2005

Keywords

  • dry powder inhalers
  • asthma
  • generic substitution

Cite this

@article{5df0a5316a914f11acb7614a1f3ed005,
title = "The way forward: dry powder inhalers should only be switched with physician agreement and patient training",
abstract = "Assessment of pharmaceutical performance, patient behaviour and clinical outcomes shows that dry powder inhalers cannot be used interchangeably, even if they contain the same active chemical entity. Consequently, there should be no switching of device without the involvement of the physician and appropriate training for the patient.",
keywords = "dry powder inhalers, asthma, generic substitution",
author = "D Price",
year = "2005",
language = "English",
volume = "59",
pages = "36--37",
journal = "International Journal of Clinical Practice",
issn = "1368-5031",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The way forward: dry powder inhalers should only be switched with physician agreement and patient training

AU - Price, D

PY - 2005

Y1 - 2005

N2 - Assessment of pharmaceutical performance, patient behaviour and clinical outcomes shows that dry powder inhalers cannot be used interchangeably, even if they contain the same active chemical entity. Consequently, there should be no switching of device without the involvement of the physician and appropriate training for the patient.

AB - Assessment of pharmaceutical performance, patient behaviour and clinical outcomes shows that dry powder inhalers cannot be used interchangeably, even if they contain the same active chemical entity. Consequently, there should be no switching of device without the involvement of the physician and appropriate training for the patient.

KW - dry powder inhalers

KW - asthma

KW - generic substitution

M3 - Literature review

VL - 59

SP - 36

EP - 37

JO - International Journal of Clinical Practice

JF - International Journal of Clinical Practice

SN - 1368-5031

ER -